Your browser doesn't support javascript.
loading
Is there any prognostic significance in pleural involvement and/or effusion in patients with ALK-positive NSCLC?
Güner, Gürkan; Aktas, Burak Yasin; Basal, Fatma Bugdayci; Demirkazik, Ahmet; Gürsoy, Pinar; Demirci, Umut; Erman, Mustafa; Yumuk, Perran Fulden; Senler, Filiz Çay; Çakar, Burcu; Çiçin, Irfan; Öztürk, Akin; Coskun, Hasan Senol; Çubukçu, Erdem; Isikdogan, Abdurrahman; Ölmez, Ömer Fatih; Tatli, Ali Murat; Karaagaç, Mustafa; Sakalar, Teoman; Eralp, Yesim; Korkmaz, Taner; Kiliçkap, Saadettin.
Afiliação
  • Güner G; Department of Medical Oncology, Hacettepe University Cancer Institute, Sihhiye, 06100, Ankara, Turkey. gunergurkan@yahoo.com.
  • Aktas BY; Department of Medical Oncology, Hacettepe University Cancer Institute, Sihhiye, 06100, Ankara, Turkey.
  • Basal FB; Lösante Hospital, Ankara, Turkey.
  • Demirkazik A; Department of Medical Oncology, Ankara University Faculty of Medicine, Ankara, Turkey.
  • Gürsoy P; Department of Medical Oncology, Ege University Faculty of Medicine, Izmir, Turkey.
  • Demirci U; Memorial Ankara Hospital, Medical Oncology Unit, Ankara, Turkey.
  • Erman M; Department of Medical Oncology, Hacettepe University Cancer Institute, Sihhiye, 06100, Ankara, Turkey.
  • Yumuk PF; Division of Medical Oncology, Department of Internal Medicine, Marmara University School of Medicine, Istanbul, Turkey.
  • Senler FÇ; Division of Medical Oncology, Koç University, School of Medicine, Istanbul, Turkey.
  • Çakar B; Department of Medical Oncology, Ankara University Faculty of Medicine, Ankara, Turkey.
  • Çiçin I; Department of Medical Oncology, Ege University Faculty of Medicine, Izmir, Turkey.
  • Öztürk A; Department of Medical Oncology, Trakya University Faculty of Medicine, Edirne, Turkey.
  • Coskun HS; Department of Medical Oncology, Sureyyapasa Chest Disease Hospital, Istanbul, Turkey.
  • Çubukçu E; Department of Medical Oncology, Akdeniz University Faculty of Medicine, Antalya, Turkey.
  • Isikdogan A; Department of Medical Oncology, Bursa Uludag University Faculty of Medicine, Bursa, Turkey.
  • Ölmez ÖF; Department of Medical Oncology, Dicle University Faculty of Medicine, Diyarbakir, Turkey.
  • Tatli AM; Department of Medical Oncology, Medipol Mega Hospitals Complex (University Hospital), Istanbul, Turkey.
  • Karaagaç M; Department of Medical Oncology, Akdeniz University Faculty of Medicine, Antalya, Turkey.
  • Sakalar T; Department of Medical Oncology, Necmettin Erbakan University School of Medicine, Konya, Turkey.
  • Eralp Y; Department of Medical Oncology, Erciyes University School of Medicine, Kayseri, Turkey.
  • Korkmaz T; Department of Medical Oncology, Acibadem University, Maslak Acibadem Hospital, Istanbul, Turkey.
  • Kiliçkap S; Department of Medical Oncology, Mehmet Ali Aydinlar Acibadem University Faculty of Medicine, Istanbul, Turkey.
J Cancer Res Clin Oncol ; 149(14): 13271-13277, 2023 Nov.
Article em En | MEDLINE | ID: mdl-37480524
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Revista: J Cancer Res Clin Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Turquia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Revista: J Cancer Res Clin Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Turquia